Credit Suisse Ag Crinetics Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 60,287 shares of CRNX stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,287

Previous 49,243 22.43%

Holding current value

$3.34 Million

Previous $1.75 Million 61.07%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$34.76 - $46.81 $383,889 - $516,969	11,044 Added 22.43%	60,287 $2.82 Million
Q4 2023 Feb 08, 2024	BUY	$25.62 - $37.07 $308,362 - $446,174	12,036 Added 32.35%	49,243 $1.75 Million
Q3 2023 Nov 13, 2023	SELL	$15.97 - $30.59 $89,256 - $170,967	-5,589 Reduced 13.06%	37,207 $1.11 Million
Q2 2023 Aug 11, 2023	BUY	$15.73 - $23.6 $174,225 - $261,393	11,076 Added 34.92%	42,796 $771,000
Q1 2023 May 10, 2023	BUY	$15.31 - $21.1 $31,201 - $43,001	2,038 Added 6.87%	31,720 $509,000
Q4 2022 Feb 13, 2023	SELL	$15.49 - $19.05 $21,438 - $26,365	-1,384 Reduced 4.46%	29,682 $543,000
Q3 2022 Nov 10, 2022	BUY	$18.11 - $22.37 $65,739 - $81,203	3,630 Added 13.23%	31,066 $611,000
Q2 2022 Aug 12, 2022	BUY	$16.49 - $27.64 $41,323 - $69,265	2,506 Added 10.05%	27,436 $511,000
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $79,112 - $130,594	4,613 Added 22.71%	24,930 $547,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $114,842 - $168,613	5,935 Added 41.27%	20,317 $577,000
Q3 2021 Nov 12, 2021	BUY	$16.88 - $25.23 $1,552 - $2,321	92 Added 0.64%	14,382 $304,000
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $60,388 - $80,327	3,798 Added 36.2%	14,290 $269,000
Q1 2021 May 14, 2021	SELL	$13.3 - $17.55 $106,107 - $140,013	-7,978 Reduced 43.19%	10,492 $160,000
Q4 2020 Feb 12, 2021	BUY	$12.08 - $17.46 $223,117 - $322,486	18,470 New	18,470 $261,000
Q3 2020 Nov 13, 2020	SELL	$13.62 - $17.66 $164,216 - $212,926	-12,057 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$13.04 - $23.23 $157,223 - $280,084	12,057 New	12,057 $211,000

Others Institutions Holding CRNX

# of Institutions

242

Shares Held

79.6M

Call Options Held

23.3K

Put Options Held

44.3K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account